1. Peptide modifications differentially alter G protein-coupled receptor internalization and signaling bias. Mäde V, Babilon S, Jolly N, Wanka L, Bellmann-Sickert K, Diaz Gimenez LE, Mörl K, Cox HM, Gurevich VV, Beck-Sickinger AG (2014) Angew Chem Int Ed Engl 53(38): 10067-71
    › Primary publication · 25065900 (PubMed) · PMC4704863 (PubMed Central)
  2. Overview of different mechanisms of arrestin-mediated signaling. Gurevich VV, Gurevich EV (2014) Curr Protoc Pharmacol : Unit 2.10.1-9
    › Primary publication · 25446289 (PubMed) · PMC4260930 (PubMed Central)
  3. Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes. Gimenez LE, Babilon S, Wanka L, Beck-Sickinger AG, Gurevich VV (2014) Cell Signal 26(7): 1523-31
    › Primary publication · 24686081 (PubMed) · PMC4033671 (PubMed Central)
  4. Identification of receptor binding-induced conformational changes in non-visual arrestins. Zhuo Y, Vishnivetskiy SA, Zhan X, Gurevich VV, Klug CS (2014) J Biol Chem 289(30): 20991-1002
    › Primary publication · 24867953 (PubMed) · PMC4110305 (PubMed Central)
  5. Extensive shape shifting underlies functional versatility of arrestins. Gurevich VV, Gurevich EV (2014) Curr Opin Cell Biol : 1-9
    › Primary publication · 24680424 (PubMed) · PMC3971385 (PubMed Central)
  6. Enhanced phosphorylation-independent arrestins and gene therapy. Gurevich VV, Song X, Vishnivetskiy SA, Gurevich EV (2014) Handb Exp Pharmacol : 133-52
    › Primary publication · 24292828 (PubMed) · PMC4516159 (PubMed Central)
  7. Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death. Kook S, Zhan X, Cleghorn WM, Benovic JL, Gurevich VV, Gurevich EV (2014) Cell Death Differ 21(1): 172-84
    › Primary publication · 24141717 (PubMed) · PMC3857626 (PubMed Central)
  8. Arrestins in apoptosis. Kook S, Gurevich VV, Gurevich EV (2014) Handb Exp Pharmacol : 309-39
    › Primary publication · 24292837 (PubMed) · PMC4516163 (PubMed Central)
  9. Arrestin makes T cells stop and become active. Gurevich VV, Gurevich EV (2014) EMBO J 33(6): 531-3
    › Primary publication · 24502974 (PubMed) · PMC3989646 (PubMed Central)
  10. Arrestin expression in E. coli and purification. Vishnivetskiy SA, Zhan X, Chen Q, Iverson TM, Gurevich VV (2014) Curr Protoc Pharmacol : Unit 2.11.1-19
    › Primary publication · 25446290 (PubMed) · PMC4260927 (PubMed Central)